PMR spectrum (300 MHz, CDCl , ꢄ, ppm): 0.84 (3H, s, CH -9), 1.33 (6H, s, CH -9ꢀ, 10ꢀ), 1.42 (3H, s, CH -8), 1.76
3
3
3
3
(2H, m, H-3ꢀ), 1.95 (1H, m, CH-8ꢀ), 2.08 (2H, m, H-5ꢀ), 2.18 (2H, m, H-4), 2.20 (1H, m, H-4ꢀ), 2.40 (2H, m, H-7), 2.42 (1H,
m, H-1), 2.52 (1H, m, H-5), 3.20 (2H, s, H-10), 3.32 (1H, m, H-6ꢀ), 4.51 (2H, s, H-7ꢀ), 5.26 (1H, m, H-3), 5.72 (1H, m, H-2ꢀ),
6.83–7.31 (3H, m, H-14-16).
13
C NMR spectrum (75 MHz, CDCl , ꢄ, ppm): 20.92 (C-10ꢀ), 20.94 (C-9ꢀ), 22.97 (C-9), 26.06 (C-8), 26.74 (C-3ꢀ),
3
26.93 (C-8ꢀ), 31.25 (C-5ꢀ), 31.39 (C-4), 36.96 (C-7), 37.85 (C-6), 38.05 (C-6ꢀ), 40.18 (C-4ꢀ), 43.16 (C-5), 44.77 (C-10), 51.23
(C-1), 70.47 (C-7ꢀ), 114.75 (C-13), 116.74 (C-15), 120.41 (C-2ꢀ), 120.73 (C-2), 122.24 (C-14), 126.54 (C-11), 128.64 (C-16),
143.90 (C-1ꢀ), 146.41 (C-2), 154.48 (C-12).
3-(2-((6,6-Dimethylbicyclo[3.1.1]hept-2-en-2-yl)methoxy)benzyl)-6,6-dimethylbicyclo[3.1.1]hept-2-ene (18) was
prepared by alkylation using the reagent method in the presence of (i-PrO) Al at 160°C (6.0% yield) and the catalytic method
3
in the presence of (i-PrO) Al at 160°C (12.0% yield).
3
PMR spectrum (300 MHz, CDCl , ꢄ, ppm): 0.82 (3H, s, CH -9), 0.83 (3H, s, CH -9ꢀ), 1.39 (3H, s, CH -8), 1.40 (3H,
3
3
3
3
s, CH -8ꢀ), 1.98 (2H, m, H-5, 5ꢀ), 2.10 (2H, m, H-4ꢀ), 2.13 (1H, m, H-1), 2.26 (2H, m, H-7ꢀ), 2.31 (1H, m, H-1ꢀ), 2.32 (2H, m,
3
H-4), 2.38 (2H, m, H-7), 3.88 (2H, s, H-10ꢀ), 4.48 (2H, s, H-10), 5.56 (1H, m, H-3ꢀ), 5.70 (1H, m, H-3), 6.81–7.37 (4H, m,
H-13-16).
13
C NMR spectrum (75 MHz, CDCl , ꢄ, ppm): 20.89 (C-8, 8ꢀ), 26.57 (C-9), 26.63 (C-9ꢀ), 31.11 (C-7), 31.27 (C-4ꢀ),
3
31.59 (C-7ꢀ), 31.78 (C-4), 35.19 (C-6), 37.82 (C-6ꢀ), 40.30 (C-5), 41.11 (C-5ꢀ), 44.53 (C-10ꢀ), 51.30 (C-1ꢀ), 72.39 (C-10),
114.72 (C-16), 119.40 (C-3), 119.92 (C-14), 120.37 (C-3ꢀ), 127.59 (C-15), 129.10 (C-13), 130.52 (C-12), 145.45 (C-2ꢀ),
145.54 (C-2), 157.56 (C-11).
3-[2-(4-Isopropenylcyclohex-1-enylmethyl)phenoxy]-2,6,6-trimethylbicyclo[3.1.1]heptane (19) was prepared by
alkylation using the reagent method in the presence of (i-PrO) Al at 140°C (20.0% yield).
3
PMR spectrum (300 MHz, CDCl , ꢄ, ppm, J/Hz): 0.89 (3H, d, J = 9.3, CH -10), 0.93 (3H, s, CH -9), 1.33 (3H, s,
3
3
3
CH -8), 1.86 (3H, s, CH -10ꢀ), 1.87 (2H, m, H-5ꢀ), 1.92 (1H, m, H-1), 1.98 (1H, m, H-2), 2.00 (1H, m, H-4ꢀ), 2.02 (2H, m,
3
3
H-4), 2.04 (2H, m, H-7), 2.09 (2H, m, H-6ꢀ), 2.25 (2H, m, H-3ꢀ), 3.12 (2H, s, H-7ꢀ), 3.48 (1H, m, H-3), 4.85 (2H, s, H-9ꢀ), 5.19
(1H, m, H-2), 6.93–7.18 (4H, m, H-13-16).
13
C NMR spectrum (75 MHz, CDCl , ꢄ, ppm): 14.07 (C-10), 21.93 (C-10ꢀ), 22.28 (C-9), 27.65 (C-8), 28.05 (C-7),
3
28.68 (C-5ꢀ), 33.90 (C-6ꢀ), 36.15 (C-3ꢀ), 36.85 (C-4), 37.23 (C-7ꢀ), 39.21 (C-6), 39.63 (C-2), 42.09 (C-4ꢀ), 43.97 (C-5), 45.73
(C-1), 80.25 (C-3), 108.96 (C-9ꢀ), 109.51 (C-16), 119.85 (C-14), 120.14 (C-2ꢀ), 127.95 (C-15), 128.02 (C-13), 130.75 (C-12),
132.15 (C-1ꢀ), 150.32 (C-8ꢀ), 157.11 (C-11).
4-(6,6-Dimethylbicyclo[3.1.1]hept-2-en-2-ylethyl)-2-(2,6,6-trimethylbicyclo[3.1.1]hept-3-yl)phenol (20) was
prepared by alkylation using the reagent method in the presence of (i-PrO) Al at 120°C (8.0% yield).
3
PMR spectrum (300 MHz, CDCl , ꢄ, ppm, J/Hz): 0.79 (3H, s, CH -9ꢀ), 0.92 (3H, s, CH -9), 1.06 (3H, d, J = 7.3,
3
3
3
CH -10), 1.28 (3H, s, CH -8ꢀ), 1.31 (3H, s, CH -8), 1.75 (2H, m, H-4), 1.79 (2H, m, H-4ꢀ), 1.81 (1H, m, H-2), 2.01 (2H, m,
3
3
3
H-7ꢀ), 2.03 (1H, m, H-5ꢀ), 2.08 (1H, m, H-1ꢀ), 2.10 (1H, m, H-1), 2.27 (2H, m, H-7), 2.33 (1H, m, H-5), 2.37 (1H, m, H-3),
3.24 (2H, s, H-10ꢀ), 5.26 (1H, m, H-3ꢀ), 6.77-7.13 (3H, m, H-13, 14, 16).
13
C NMR spectrum (75 MHz, CDCl , ꢄ, ppm): 19.84 (C-9), 20.29 (C-82), 21.61 (C-10), 26.25 (C-9ꢀ), 26.40 (C-8),
3
27.74 (C-7), 29.73 (C-4), 29.88 (C-4ꢀ), 31.38 (C-7ꢀ), 31.83 (C-2), 36.67 (C-6), 37.89 (C-6ꢀ), 40.73 (C-3), 41.09 (C-5), 41.34
(C-10ꢀ), 42.64 (C-5ꢀ), 45.46 (C-1), 46.21 (C-1ꢀ), 114.97 (C-13), 117.36 (C-3ꢀ), 129.87 (C-14), 130.27 (C-16), 131.42 (C-15),
131.67 (C-11), 147.72 (C-2ꢀ), 153.76 (C-12).
2,4-bis-[1-Methyl-1-(4-methylcyclohexyl)ethyl]phenol (21) was prepared by alkylation using the reagent method
in the presence of (PhO) Al at 160°C (2.0% yield).
3
PMR spectrum (300 MHz, CDCl , ꢄ, ppm): 0.88 (3H, m, CH -7), 0.90 (3H, m, CH -7ꢀ), 1.05 (3H, s, CH -9ꢀ), 1.08
3
3
3
3
(3H, s, CH -10ꢀ), 1.25 (2H, m, H-1, 1ꢀ), 1.27–1.30 (16H, m, H-2, 3, 5, 6, 2ꢀ, 3ꢀ, 5ꢀ, 6ꢀ), 1.39 (3H, s, CH -9), 1.42 (3H, s,
3
3
CH -10), 1.52–1.58 (2H, m, H-4, 4ꢀ), 7.19–7.62 (3H, m, H-13, 14, 16).
3
13
C NMR spectrum (75 MHz, CDCl , ꢄ, ppm): 18.67 (C-7), 20.13 (C-7ꢀ), 23.05 (C-9, 10), 28.23 (C-9ꢀ, 10ꢀ), 29.72
3
(C-3, 3ꢀ, 5, 5ꢀ), 30.08 (C-2, 2ꢀ, 6, 6ꢀ), 31.95 (C-1, 1ꢀ), 37.12 (C-8ꢀ), 37.43 (C-8), 40.64 (C-4, 4ꢀ), 119.73 (C-13), 121.86 (C-16),
122.61 (C-14), 132.87 (C-11), 140.67 (C-15), 150.29 (C-12).
2-(6,6-Dimethylbicyclo[3.1.1]hept-2-en-2-ylethyl)-6-(1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)phenol (22) was
prepared by alkylation using the reagent method in the presence of (i-PrO) Al at 160°C (9.0% yield).
3
PMR spectrum (300 MHz, CDCl , ꢄ, ppm): 0.79 (3H, s, CH -9), 0.85 (3H, s, CH -10ꢀ), 1.07 (3H, s, CH -9ꢀ), 1.09
3
3
3
3
(3H, s, CH -8ꢀ), 1.20 (3H, s, CH -8), 1.23 (2H, m, H-3ꢀ), 1.41 (2H, m, H-2ꢀ), 1.62 (2H, m, H-4), 1.66 (1H, m, H-4ꢀ), 1.78 (1H,
3
3
563